See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621443_2016_Zynerba_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001621443, Zynerba Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,415,695 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 227,646 |
| 3 | remainder_Assets | 200 |
| 4 | LiabilitiesCurrent | 3,937,617 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,364,390 |
| 9 | ResearchAndDevelopmentExpense | 7,445,669 |
| 10 | remainder_Expenses | 27,543 |
| 11 | remainder_Revenues | 278,900 |
| 12 | remainder_NetIncome | 7,352 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,643,541 |
| 1 | Liabilities | 3,937,617 |
| 2 | Expenses | 12,837,602 |
| 3 | Revenues | 278,900 |
| 4 | StockholdersEquity | 39,705,924 |
| 5 | NetIncome | -12,551,350 |
| 6 | ComprehensiveNetIncome | -12,551,350 |
| 7 | BaseVar | 30,352,506 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.11 |
| 9 | EconomicCapitalRatio | 3.76 |
Edgar->Model Mapping
Feature Distribution
